Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 600

1.

Improvement in Touch Sensation after Stroke is Associated with Resting Functional Connectivity Changes.

Bannister LC, Crewther SG, Gavrilescu M, Carey LM.

Front Neurol. 2015 Jul 31;6:165. doi: 10.3389/fneur.2015.00165. eCollection 2015.

2.

Slow-growing cells within isogenic populations have increased RNA polymerase error rates and DNA damage.

van Dijk D, Dhar R, Missarova AM, Espinar L, Blevins WR, Lehner B, Carey LB.

Nat Commun. 2015 Aug 13;6:7972. doi: 10.1038/ncomms8972.

PMID:
26268986
3.

Neoadjuvant clinical trial designs: Challenges of the genomic era.

Carey LA.

Breast. 2015 Aug 1. pii: S0960-9776(15)00159-9. doi: 10.1016/j.breast.2015.07.021. [Epub ahead of print]

PMID:
26243441
4.

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.

Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Troester MA, Carey LA, Wheeler SB.

Breast Cancer Res Treat. 2015 Aug;153(1):191-200. doi: 10.1007/s10549-015-3518-9. Epub 2015 Jul 28.

PMID:
26216535
5.

Sponsor-Imposed Publication Restrictions Disclosed on ClinicalTrials.gov.

Stretton S, Lew RA, Ely JA, Snape MJ, Carey LC, Haley C, Woolley MJ, Woolley KL.

Account Res. 2015 Jul 20. [Epub ahead of print]

PMID:
26193425
6.

Tissue-Specific Effects of Esophageal Extracellular Matrix.

Keane TJ, DeWard A, Londono R, Saldin LT, Castleton AA, Carey L, Nieponice A, Lagasse E, Badylak SF.

Tissue Eng Part A. 2015 Sep;21(17-18):2293-300. doi: 10.1089/ten.TEA.2015.0322.

PMID:
26192009
7.

Palbociclib--Taking Breast-Cancer Cells Out of Gear.

Carey LA, Perou CM.

N Engl J Med. 2015 Jul 16;373(3):273-4. doi: 10.1056/NEJMe1506680. No abstract available.

PMID:
26176385
8.

Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.

Silva GO, He X, Parker JS, Gatza ML, Carey LA, Hou JP, Moulder SL, Marcom PK, Ma J, Rosen JM, Perou CM.

Breast Cancer Res Treat. 2015 Jul;152(2):347-56. doi: 10.1007/s10549-015-3476-2. Epub 2015 Jun 25.

9.

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance).

Rugo HS, Barry WT, Moreno-Aspitia A, Lyss AP, Cirrincione C, Leung E, Mayer EL, Naughton M, Toppmeyer D, Carey LA, Perez EA, Hudis C, Winer EP.

J Clin Oncol. 2015 Jul 20;33(21):2361-9. doi: 10.1200/JCO.2014.59.5298. Epub 2015 Jun 8.

PMID:
26056183
10.

Proteogenomic Analysis Identifies a Novel Human SHANK3 Isoform.

Benthani F, Tran PN, Currey N, Ng I, Giry-Laterriere M, Carey L, Kohonen-Corish MR, Pangon L.

Int J Mol Sci. 2015 May 19;16(5):11522-30. doi: 10.3390/ijms160511522.

11.

Chemotherapy-related amenorrhea after adjuvant paclitaxel-trastuzumab (APT trial).

Ruddy KJ, Guo H, Barry W, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis MJ, Shapira I, Wolff AC, Carey LA, Overmoyer BA, Hudis C, Krop IE, Burstein HJ, Winer EP, Partridge AH, Tolaney SM.

Breast Cancer Res Treat. 2015 Jun;151(3):589-96. doi: 10.1007/s10549-015-3426-z. Epub 2015 May 16.

PMID:
25981899
12.

Defining breast cancer intrinsic subtypes by quantitative receptor expression.

Cheang MC, Martin M, Nielsen TO, Prat A, Voduc D, Rodriguez-Lescure A, Ruiz A, Chia S, Shepherd L, Ruiz-Borrego M, Calvo L, Alba E, Carrasco E, Caballero R, Tu D, Pritchard KI, Levine MN, Bramwell VH, Parker J, Bernard PS, Ellis MJ, Perou CM, Di Leo A, Carey LA.

Oncologist. 2015 May;20(5):474-82. doi: 10.1634/theoncologist.2014-0372. Epub 2015 Apr 23.

PMID:
25908555
13.

In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.

Hertz DL, Snavely AC, McLeod HL, Walko CM, Ibrahim JG, Anderson S, Weck KE, Magrinat G, Olajide O, Moore S, Raab R, Carrizosa DR, Corso S, Schwartz G, Peppercorn JM, Evans JP, Jones DR, Desta Z, Flockhart DA, Carey LA, Irvin WJ Jr.

Br J Clin Pharmacol. 2015 Apr 24. doi: 10.1111/bcp.12665. [Epub ahead of print]

PMID:
25907378
14.

Measuring change in somatosensation across the lifespan.

Dunn W, Griffith JW, Sabata D, Morrison MT, MacDermid JC, Darragh A, Schaaf R, Dudgeon B, Connor LT, Carey L, Tanquary J.

Am J Occup Ther. 2015 May-Jun;69(3):6903290020p1-9. doi: 10.5014/ajot.2015.014845.

15.

Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains.

Stuhlmiller TJ, Miller SM, Zawistowski JS, Nakamura K, Beltran AS, Duncan JS, Angus SP, Collins KA, Granger DA, Reuther RA, Graves LM, Gomez SM, Kuan PF, Parker JS, Chen X, Sciaky N, Carey LA, Earp HS, Jin J, Johnson GL.

Cell Rep. 2015 Apr 21;11(3):390-404. doi: 10.1016/j.celrep.2015.03.037. Epub 2015 Apr 9.

16.

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

Isakoff SJ, Mayer EL, He L, Traina TA, Carey LA, Krag KJ, Rugo HS, Liu MC, Stearns V, Come SE, Timms KM, Hartman AR, Borger DR, Finkelstein DM, Garber JE, Ryan PD, Winer EP, Goss PE, Ellisen LW.

J Clin Oncol. 2015 Jun 10;33(17):1902-9. doi: 10.1200/JCO.2014.57.6660. Epub 2015 Apr 6.

PMID:
25847936
17.

Race, response to chemotherapy, and outcome within clinical breast cancer subtypes.

Tichy JR, Deal AM, Anders CK, Reeder-Hayes K, Carey LA.

Breast Cancer Res Treat. 2015 Apr;150(3):667-74. doi: 10.1007/s10549-015-3350-2. Epub 2015 Mar 27.

PMID:
25814053
18.

Old drugs, new tricks for triple-negative breast cancer.

Carey L.

Lancet Oncol. 2015 Apr;16(4):357-9. doi: 10.1016/S1470-2045(15)70108-7. Epub 2015 Mar 18. No abstract available.

PMID:
25795403
19.

A meta-analysis of changes in brain activity in clinical depression.

Palmer SM, Crewther SG, Carey LM; START Project Team.

Front Hum Neurosci. 2015 Jan 14;8:1045. doi: 10.3389/fnhum.2014.01045. eCollection 2014.

20.

Editorial: Democratic leadership: a charming solution for nursing's legitimacy crisis.

McKeown M, Carey L.

J Clin Nurs. 2015 Feb;24(3-4):315-7. doi: 10.1111/jocn.12752. No abstract available.

PMID:
25626376
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk